Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Markets Mixed

<< Previous

Bullboard Posts

Next >>

Comment by woundedkneeon Mar 08, 2021 11:35am

118 Views

Post# 32743278

RE:RE:RE:RE:RE:RE:Markets Mixed

Hideaway, Maybe you could inbox me and tell me why America is better off. And it's not a stuttering problem. Pelosi cut him off the other day when he offered to take questions, and in Texas just last week during a speech, he couldn't find his note card and didn't know the names of people he was thanking and said what am 'I doing here". No, he has serious problems and unfortunately the world knows it.
Kamala is taking over even as we speak.

My biggest problem now is to get ATE back over 5 bucks and not Joe Biden

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?